• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴结清扫范围改善了根治性肾切除术后 pT3N0 无转移肾细胞癌患者的总生存:基于倾向评分的分析。

Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis.

机构信息

Department of Urology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, 322100, Zhejiang, People's Republic of China.

Department of Clinical Laboratory, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, 322100, Zhejiang, People's Republic of China.

出版信息

World J Urol. 2020 Jun;38(6):1579-1585. doi: 10.1007/s00345-019-02788-6. Epub 2019 May 7.

DOI:10.1007/s00345-019-02788-6
PMID:31065795
Abstract

BACKGROUND

To assess the impact of lymph node dissection (LND) extent on overall survival (OS) and cancer-specific survival (CSS) in patients with pN0M0 renal cell carcinoma (RCC) treated with radical nephrectomy (RN).

MATERIALS AND METHODS

Data queried for this study include RCC (2010-2014) from the Surveillance, Epidemiology, and End Results (SEER) program. Kaplan-Meier analyses and multivariate Cox regression models tested the effect of number of removed lymph node (NRN) ≥ 50th percentile on OS and CSS. The associations were evaluated using propensity score (PS) matching adjustment.

RESULTS

A total of 5532 pN0M0 RCC patients were enrolled in our study. The median NRN was 2 (IQR 1-6), the 50th percentile defined patients with NRN ≥ 2. Following PS adjustment, there were no significant differences in clinicopathologic features between two groups of patients except for age. Multivariate model analysis showed that patients with NRN < 2 had worse OS than those with NRN ≥ 2 in pT3 group (HR 1.442; P = 0.032) but not in pT1 and pT2 groups (HR 0.859 and 1.393, P = 0.443 and P = 0.267, respectively). However, patients with NRN < 2 had better CCS than those with NRN ≥ 2 in pT1 group (HR 0.368; P = 0.016) but not in pT2 and pT3 groups (HR 1.674 and 1.325, P = 0.216 and P = 0.176, respectively).

CONCLUSIONS

More extensive LND (NRN ≥ 2) at RN is associated with better OS in pT3N0M0 RCC patients while it exerts negative influence on CCS in pT1N0M0 group. Hence, more extensive LND has therapeutic value in pT3 individuals but not in pT1 group.

摘要

背景

评估淋巴结清扫术(LND)范围对接受根治性肾切除术(RN)治疗的 pN0M0 肾细胞癌(RCC)患者总生存(OS)和癌症特异性生存(CSS)的影响。

材料和方法

本研究的数据来自监测、流行病学和最终结果(SEER)计划中的 RCC(2010-2014 年)。Kaplan-Meier 分析和多变量 Cox 回归模型测试了移除的淋巴结数量(NRN)≥第 50 个百分位数对 OS 和 CSS 的影响。使用倾向评分(PS)匹配调整评估相关性。

结果

共纳入 5532 例 pN0M0 RCC 患者。NRN 的中位数为 2(IQR 1-6),第 50 个百分位数定义为 NRN≥2 的患者。在 PS 调整后,两组患者的临床病理特征除年龄外无显著差异。多变量模型分析显示,NRN<2 的患者在 pT3 组的 OS 差于 NRN≥2 的患者(HR 1.442;P=0.032),但在 pT1 和 pT2 组中无显著差异(HR 分别为 0.859 和 1.393,P=0.443 和 P=0.267)。然而,NRN<2 的患者在 pT1 组的 CSS 优于 NRN≥2 的患者(HR 0.368;P=0.016),但在 pT2 和 pT3 组中无显著差异(HR 分别为 1.674 和 1.325,P=0.216 和 P=0.176)。

结论

在接受 RN 的 pT3N0M0 RCC 患者中,更广泛的 LND(NRN≥2)与 OS 改善相关,而在 pT1N0M0 组中,LND 对 CSS 产生负面影响。因此,更广泛的 LND 在 pT3 个体中有治疗价值,但在 pT1 组中没有。

相似文献

1
Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis.淋巴结清扫范围改善了根治性肾切除术后 pT3N0 无转移肾细胞癌患者的总生存:基于倾向评分的分析。
World J Urol. 2020 Jun;38(6):1579-1585. doi: 10.1007/s00345-019-02788-6. Epub 2019 May 7.
2
The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT non-metastatic renal cell carcinoma treated with radical nephrectomy.淋巴结清扫和阳性淋巴结对接受根治性肾切除术治疗的当代pT期非转移性肾细胞癌患者癌症特异性死亡率的影响。
BJU Int. 2018 Mar;121(3):383-392. doi: 10.1111/bju.14024. Epub 2017 Oct 12.
3
Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.根治性肾切除术联合或不联合淋巴结清扫术治疗非转移性肾细胞癌:基于倾向评分的分析。
Eur Urol. 2017 Apr;71(4):560-567. doi: 10.1016/j.eururo.2016.09.019. Epub 2016 Sep 24.
4
Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma.模拟针对肾细胞癌的根治性肾切除术联合或不联合淋巴结清扫术的临床试验。
Urology. 2020 Jun;140:98-106. doi: 10.1016/j.urology.2020.01.039. Epub 2020 Mar 4.
5
The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013.2006年至2013年手术切除后孤立性淋巴结转移肾细胞癌的自然病史。
Urol Oncol. 2019 Dec;37(12):932-940. doi: 10.1016/j.urolonc.2019.08.003. Epub 2019 Sep 27.
6
Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.淋巴结清扫术的范围并不能提高有淋巴结转移的肾细胞癌患者的生存率:与缺失数据处理相关的偏倚。
BJU Int. 2014 Jan;113(1):36-42. doi: 10.1111/j.1464-410X.2012.11693.x. Epub 2013 Mar 12.
7
Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).肾切除术时淋巴结清扫范围影响肾细胞癌(RCC)特定亚组患者的癌症特异性生存率和转移进展。
BJU Int. 2014 Aug;114(2):210-5. doi: 10.1111/bju.12508. Epub 2014 May 22.
8
Valuation of lymph node dissection in localized high-risk renal cell cancer using X-tile software.使用 X-tile 软件对局限性高危肾细胞癌的淋巴结清扫进行评估。
Int Urol Nephrol. 2020 Feb;52(2):253-262. doi: 10.1007/s11255-019-02307-x. Epub 2019 Oct 14.
9
Lymph node dissection during radical nephrectomy: A Canadian multi-institutional analysis.根治性肾切除术中的淋巴结清扫:一项加拿大多机构分析。
Urol Oncol. 2021 Jun;39(6):371.e17-371.e25. doi: 10.1016/j.urolonc.2021.02.025. Epub 2021 Mar 27.
10
Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.在接受根治性前列腺切除术且无淋巴结侵犯的前列腺癌患者中,淋巴结清扫范围可提高生存率。
Prostate. 2018 May;78(6):469-475. doi: 10.1002/pros.23491. Epub 2018 Feb 19.

引用本文的文献

1
The Current Role of Lymph Node Dissection in Nonmetastatic Localized Renal Cell Carcinoma.淋巴结清扫术在非转移性局限性肾细胞癌中的当前作用
J Clin Med. 2023 May 29;12(11):3732. doi: 10.3390/jcm12113732.
2
Potential benefit of lymph node dissection during radical nephrectomy for kidney cancer: A review and critical analysis of current literature.肾癌根治性肾切除术期间淋巴结清扫的潜在益处:当前文献综述与批判性分析
Asian J Urol. 2022 Jul;9(3):215-226. doi: 10.1016/j.ajur.2022.03.007. Epub 2022 May 27.

本文引用的文献

1
Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.根治性肾切除术联合或不联合淋巴结清扫术治疗非转移性肾细胞癌:基于倾向评分的分析。
Eur Urol. 2017 Apr;71(4):560-567. doi: 10.1016/j.eururo.2016.09.019. Epub 2016 Sep 24.
2
Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis.淋巴结清扫术与接受细胞减灭性肾切除术治疗转移性肾细胞癌患者的生存改善无关:基于倾向评分的分析。
J Urol. 2017 Mar;197(3 Pt 1):574-579. doi: 10.1016/j.juro.2016.09.074. Epub 2016 Sep 20.
3
Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
肾切除术时淋巴结清扫范围影响肾细胞癌(RCC)特定亚组患者的癌症特异性生存率和转移进展。
BJU Int. 2014 Aug;114(2):210-5. doi: 10.1111/bju.12508. Epub 2014 May 22.
4
Lymph node dissection during cytoreductive nephrectomy: a retrospective analysis.减瘤性肾切除术中的淋巴结清扫:一项回顾性分析
Int J Urol. 2014 Sep;21(9):874-9. doi: 10.1111/iju.12457. Epub 2014 Apr 8.
5
Analysis of lymph node dissection in patients with ≥7-cm renal tumors.≥7厘米肾肿瘤患者的淋巴结清扫分析
World J Urol. 2014 Dec;32(6):1531-6. doi: 10.1007/s00345-013-1233-x. Epub 2014 Jan 9.
6
Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?对于病理淋巴结阳性的肾细胞癌患者,手术切除能否实现持久无病生存?
J Urol. 2011 Oct;186(4):1236-41. doi: 10.1016/j.juro.2011.05.051. Epub 2011 Aug 17.
7
Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases.淋巴结清扫术可提高有淋巴结转移的肾细胞癌患者的生存率。
J Urol. 2011 May;185(5):1615-20. doi: 10.1016/j.juro.2010.12.053. Epub 2011 Mar 21.
8
Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881.根治性肾切除术伴或不伴淋巴结清扫术:欧洲癌症研究与治疗组织(EORTC)随机 3 期试验 30881 的最终结果。
Eur Urol. 2009 Jan;55(1):28-34. doi: 10.1016/j.eururo.2008.09.052. Epub 2008 Oct 1.
9
A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.一项利用原发性肿瘤病理特征对接受根治性肾切除术治疗的透明细胞肾细胞癌患者进行扩大淋巴结清扫的方案。
J Urol. 2004 Aug;172(2):465-9. doi: 10.1097/01.ju.0000129815.91927.85.
10
Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.伴有腹膜后淋巴结转移的肾细胞癌。对生存的影响及免疫治疗的益处。
Cancer. 2003 Jun 15;97(12):2995-3002. doi: 10.1002/cncr.11422.